Literature DB >> 12794715

Influence of hepatitis B virus genotypes on the development of preS deletions and advanced liver disease.

Fuminaka Sugauchi1, Tomoyoshi Ohno, Etsuro Orito, Hiroshi Sakugawa, Takafumi Ichida, Masafumi Komatsu, Tomoyuki Kuramitsu, Ryuzo Ueda, Yuzo Miyakawa, Masashi Mizokami.   

Abstract

Hepatitis B virus (HBV) mutants with deletions in the preS region have not been evaluated for association with viral genotypes. In a case-control study, HBV DNA samples collected from 80 each of carriers infected with HBV genotype B or C were examined for preS deletions. PreS deletion mutants were found in a total of 37 of 160 (23%) HBV carriers. Carriers with preS deletion mutants were older (56.0 +/- 12.7 vs 49.3 +/- 16.9 years, P < 0.05), were infected more frequently with HBV genotype C (84% vs 40%, P < 0.05), and had more advanced disease, such as liver cirrhosis and hepatocellular carcinoma (54% vs 31%; P < 0.05), than did those without such mutants. In a multivariate analysis, genotype C (odds ratio [OR] = 9.3, P < 0.001) and advanced liver disease (OR = 3.1, P < 0.01) were the most significant variables in association with preS deletions. A direct repeat sequence (TCAGG) was found at the start or at the end of preS1 deletions in 6 of the 20 (30%) cases examined, and preS2 deletions in these cases were clustered over the 5'-terminal half of this region. These results indicate that the development of preS deletion mutants depends on HBV genotypes and that it may be associated with progressive liver disease. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12794715     DOI: 10.1002/jmv.10428

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  42 in total

1.  Current status of antiviral therapy for hepatitis B.

Authors:  Daryl T-Y Lau; Wissam Bleibel
Journal:  Therap Adv Gastroenterol       Date:  2008-07       Impact factor: 4.409

2.  Hepatitis B virus subgenotype A1 predominates in liver disease patients from Kerala, India.

Authors:  Deepak Gopalakrishnan; Mark Keyter; Kotacherry Trivikrama Shenoy; Kondarappassery Balakumaran Leena; Lakshmikanthan Thayumanavan; Varghese Thomas; Kr Vinayakumar; Charles Panackel; Arun T Korah; Ramesh Nair; Anna Kramvis
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

Review 3.  Genotypes and viral variants in chronic hepatitis B: A review of epidemiology and clinical relevance.

Authors:  Catherine Mn Croagh; Paul V Desmond; Sally J Bell
Journal:  World J Hepatol       Date:  2015-03-27

4.  Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in Qidong, China.

Authors:  Li-Shuai Qu; Jin-Xia Liu; Tao-Tao Liu; Xi-Zhong Shen; Tao-Yang Chen; Zheng-Pin Ni; Cui-Hua Lu
Journal:  PLoS One       Date:  2014-05-21       Impact factor: 3.240

5.  Novel type of hepatitis B virus mutation: replacement mutation involving a hepatocyte nuclear factor 1 binding site tandem repeat in chronic hepatitis B virus genotype E.

Authors:  Kei Fujiwara; Yasuhito Tanaka; Emma Paulon; Etsuro Orito; Masaya Sugiyama; Kiyoaki Ito; Ryuzo Ueda; Masashi Mizokami; Nikolai V Naoumov
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 6.  DNA markers in molecular diagnostics for hepatocellular carcinoma.

Authors:  Ying-Hsiu Su; Selena Y Lin; Wei Song; Surbhi Jain
Journal:  Expert Rev Mol Diagn       Date:  2014-08-07       Impact factor: 5.225

7.  Hepatitis B viral surface mutations in patients with adefovir resistant chronic hepatitis B with A181T/V polymerase mutations.

Authors:  Jeong Han Kim; Young Kul Jung; Moon Kyung Joo; Ji Hoon Kim; Hyung Joon Yim; Jong-Jae Park; Jae Seon Kim; Young-Tae Bak; Jong Eun Yeon; Kwan Soo Byun
Journal:  J Korean Med Sci       Date:  2009-01-19       Impact factor: 2.153

Review 8.  Molecular identification of hepatitis B virus genotypes/subgenotypes: revised classification hurdles and updated resolutions.

Authors:  Mahmoud Reza Pourkarim; Samad Amini-Bavil-Olyaee; Fuat Kurbanov; Marc Van Ranst; Frank Tacke
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

9.  Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.

Authors:  Shijian Liu; Hongwei Zhang; Chunying Gu; Jianhua Yin; Yongchao He; Jiaxin Xie; Guangwen Cao
Journal:  J Natl Cancer Inst       Date:  2009-07-02       Impact factor: 13.506

10.  Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study.

Authors:  Zhong-Liao Fang; Caroline A Sabin; Bai-Qing Dong; Shao-Chao Wei; Qin-Yan Chen; Kong-Xiong Fang; Jin-Ye Yang; Jian Huang; Xue-Yan Wang; Tim J Harrison
Journal:  J Gen Virol       Date:  2008-11       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.